Sakar Healthcare (India) Performance
| SAKAR Stock | 294.50 2.55 0.87% |
The entity has a beta of 0.0045, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Sakar Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sakar Healthcare is expected to be smaller as well. At this point, Sakar Healthcare has a negative expected return of -0.0206%. Please make sure to validate Sakar Healthcare's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Sakar Healthcare performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Sakar Healthcare Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward-looking signals, Sakar Healthcare is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
1 | Zota Health Care surges 24 percent this week, taking five-year gains to 460 percent - Simply Wall St | 01/08/2025 |
| Begin Period Cash Flow | 933 K |
Sakar |
Sakar Healthcare Relative Risk vs. Return Landscape
If you would invest 30,215 in Sakar Healthcare Limited on October 25, 2024 and sell it today you would lose (765.00) from holding Sakar Healthcare Limited or give up 2.53% of portfolio value over 90 days. Sakar Healthcare Limited is generating negative expected returns and assumes 2.0933% volatility on return distribution over the 90 days horizon. Simply put, 18% of stocks are less volatile than Sakar, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Sakar Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sakar Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sakar Healthcare Limited, and traders can use it to determine the average amount a Sakar Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0098
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SAKAR |
Estimated Market Risk
| 2.09 actual daily | 18 82% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sakar Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sakar Healthcare by adding Sakar Healthcare to a well-diversified portfolio.
Sakar Healthcare Fundamentals Growth
Sakar Stock prices reflect investors' perceptions of the future prospects and financial health of Sakar Healthcare, and Sakar Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sakar Stock performance.
| Return On Equity | 0.049 | ||||
| Return On Asset | 0.039 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 7.09 B | ||||
| Shares Outstanding | 21.75 M | ||||
| Price To Book | 2.36 X | ||||
| Price To Sales | 4.00 X | ||||
| Revenue | 1.54 B | ||||
| Gross Profit | 738.93 M | ||||
| EBITDA | 393.27 M | ||||
| Net Income | 116.71 M | ||||
| Cash And Equivalents | 933 K | ||||
| Total Debt | 793.52 M | ||||
| Book Value Per Share | 243.80 X | ||||
| Cash Flow From Operations | 244.67 M | ||||
| Earnings Per Share | 5.95 X | ||||
| Total Asset | 3.95 B | ||||
| Retained Earnings | 805.36 M | ||||
About Sakar Healthcare Performance
By examining Sakar Healthcare's fundamental ratios, stakeholders can obtain critical insights into Sakar Healthcare's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Sakar Healthcare is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Sakar Healthcare is entity of India. It is traded as Stock on NSE exchange.Things to note about Sakar Healthcare performance evaluation
Checking the ongoing alerts about Sakar Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sakar Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sakar Healthcare generated a negative expected return over the last 90 days | |
| Sakar Healthcare is unlikely to experience financial distress in the next 2 years | |
| Latest headline from news.google.com: Zota Health Care surges 24 percent this week, taking five-year gains to 460 percent - Simply Wall St |
- Analyzing Sakar Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sakar Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Sakar Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sakar Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sakar Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sakar Healthcare's stock. These opinions can provide insight into Sakar Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Sakar Stock
Sakar Healthcare financial ratios help investors to determine whether Sakar Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sakar with respect to the benefits of owning Sakar Healthcare security.